The observation in N IgA responses was by trend accompanied by enhanced levels of N IgG (p=0.078), Spike-1 IgA and Spike-RBD IgA (both p=0.069), all of them independent of the COVID-19 status. This evidence concerns the gene CHMP5 and COVID-19.